The quality of life impact of acute exacerbations of chronic bronchitis (AECB): A literature review

[1]  T. Seemungal,et al.  Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.

[2]  S. Sethi.  New developments in the pathogenesis of acute exacerbations of chronic obstructive pulmonary disease , 2004, Current opinion in infectious diseases.

[3]  H. Doll,et al.  Validity of the St George's respiratory questionnaire at acute exacerbation of chronic bronchitis: Comparison with the Nottingham health profile , 2003, Quality of Life Research.

[4]  M. Campbell,et al.  Assessing patient outcomes in acute exacerbations of chronic bronchitis: The measure your medical outcome profile (MYMOP), medical outcomes study 6-item general health survey (MOS-6A) and EuroQol (EQ-5D) , 2004, Quality of Life Research.

[5]  S. Spencer,et al.  Time course of recovery of health status following an infective exacerbation of chronic bronchitis , 2003, Thorax.

[6]  I. Stiell,et al.  Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. , 2003, The New England journal of medicine.

[7]  S. Sethi.  The role of antibiotics in acute exacerbations of chronic obstructive pulmonary disease , 2003, Current infectious disease reports.

[8]  E. Clini,et al.  Predictors of change in exercise capacity after comprehensive COPD inpatient rehabilitation. , 2002, Medical science monitor : international medical journal of experimental and clinical research.

[9]  S. Larsson,et al.  Long-term oxygen therapy and quality of life in elderly patients hospitalised due to severe exacerbation of COPD. A 1 year follow-up study. , 2002, Respiratory medicine.

[10]  Shin-Ping Tu,et al.  Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases. , 2002, Chest.

[11]  S. Quintana,et al.  Mortality after hospitalization for COPD. , 2002, Chest.

[12]  S. Aaron,et al.  Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation. , 2002, Chest.

[13]  H. Doll,et al.  Quality of life in acute exacerbation of chronic bronchitis: results from a German population study. , 2002, Respiratory medicine.

[14]  R. Hornung,et al.  Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis. , 2002, Chest.

[15]  P. Jones,et al.  Health status measurement in chronic obstructive pulmonary disease , 2001, Thorax.

[16]  M. Sullivan,et al.  Health-related quality of life in COPD: why both disease-specific and generic measures should be used. , 2001, The European respiratory journal.

[17]  J. Lorenz,et al.  Treatment Outcomes in Acute Exacerbations of Chronic Bronchitis: Comparison of Macrolides and Moxifloxacin from the Patient Perspective , 2001, The Journal of international medical research.

[18]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[19]  D. Revicki,et al.  The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. , 2001, Archives of internal medicine.

[20]  Christine Jenkins,et al.  GOLD SCIENTIFIC COMMITTEE. GLOBAL STRATEGY FOR THE DIAGNOSIS, MANAGEMENT, AND PREVENTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. NHLBI/WHO GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (COLD) WORKSHOP SUMMARY , 2001 .

[21]  H. Magnussen,et al.  Home-based exercise is capable of preserving hospital-based improvements in severe chronic obstructive pulmonary disease. , 2000, Respiratory medicine.

[22]  R M Angus,et al.  “Hospital at home” versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial , 2000, BMJ : British Medical Journal.

[23]  J. Miller,et al.  Lung volume reduction surgery: results of a Canadian pilot study. Canadian Lung Volume Reduction Surgery Study Group. , 2000, Canadian journal of surgery. Journal canadien de chirurgie.

[24]  R. Wagenaar,et al.  The long-term effects of pulmonary rehabilitation in patients with asthma and chronic obstructive pulmonary disease: a research synthesis. , 1999, Archives of physical medicine and rehabilitation.

[25]  A. Anzueto,et al.  Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  T. Seemungal,et al.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[27]  R. Cook,et al.  A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group. , 1998, Chest.

[28]  J. Spertus,et al.  A new self-administered questionnaire to monitor health-related quality of life in patients with COPD. Ambulatory Care Quality Improvement Project (ACQUIP) Investigators. , 1997, Chest.

[29]  J. Martin,et al.  Impact of nutritional support on functional status during an acute exacerbation of chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.

[30]  P. Jones,et al.  Quality of life changes in COPD patients treated with salmeterol. , 1997, American journal of respiratory and critical care medicine.

[31]  F. Guillemin,et al.  Health-Related Quality of Life in Long Term Oxygen-Treated Chronic Obstructive Pulmonary Disease Patients , 1997, Lung.

[32]  J. G. Douglas,et al.  Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. , 1997, Thorax.

[33]  L Goldman,et al.  Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.

[34]  D. Redelmeier,et al.  Spirometry and dyspnea in patients with COPD. When small differences mean little. , 1996, Chest.

[35]  C. Paterson.  Measuring outcomes in primary care: a patient generated measure, MYMOP, compared with the SF-36 health survey , 1996, BMJ.

[36]  J C Yernault,et al.  Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.

[37]  P. Jones,et al.  Issues concerning health-related quality of life in COPD. , 1995, Chest.

[38]  G. Nappi,et al.  Headache and Quality of Life , 1995, Headache.

[39]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[40]  C. Sherbourne,et al.  The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. , 1994 .

[41]  C. McHorney,et al.  The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs , 1993, Medical care.

[42]  Ware J.E.Jr.,et al.  THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .

[43]  P. Jones,et al.  The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.

[44]  A. Williams.  EuroQol : a new facility for the measurement of health-related quality of life , 1990 .

[45]  John E. Ware,et al.  SF-36 Health Survey. , 1990 .

[46]  A. Kasuya.  EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.

[47]  Traver Ga.  Measures of symptoms and life quality to predict emergent use of institutional health care resources in chronic obstructive airways disease. , 1988 .

[48]  G. Traver.  Measures of symptoms and life quality to predict emergent use of institutional health care resources in chronic obstructive airways disease. , 1988, Heart & lung : the journal of critical care.

[49]  G. Guyatt,et al.  A measure of quality of life for clinical trials in chronic lung disease. , 1987, Thorax.

[50]  I. McDowell,et al.  Measuring health: A guide to rating scales and questionnaires, 3rd ed. , 2006 .

[51]  N. Anthonisen,et al.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.

[52]  G W Torrance,et al.  Utility approach to measuring health-related quality of life. , 1987, Journal of chronic diseases.

[53]  S P McKenna,et al.  Measuring health status: a new tool for clinicians and epidemiologists. , 1985, The Journal of the Royal College of General Practitioners.

[54]  M. Bergner,et al.  The Sickness Impact Profile: Development and Final Revision of a Health Status Measure , 1981, Medical care.